CN Patent

CN116925037B — 一种2-氨基-6-(1-甲基哌啶-4-基羰基)吡啶的制备方法

Assigned to Shandong New Time Pharmaceutical Co Ltd · Expires 2026-04-07 · 0y expired

What this patent protects

本发明属于药物合成技术领域，具体涉及一种2‑氨基‑6‑(1‑甲基哌啶‑4‑基羰基)吡啶的制备方法；本方法以2‑溴‑6‑(1‑甲基哌啶‑4‑基羰基)‑吡啶为起始原料，在L‑脯氨酸和催化剂作用下制得2‑氨基‑6‑(1‑甲基哌啶‑4‑基羰基)吡啶，可以有效降低杂质生成，且操作简单，反应条件温和，制得的化合物I收率高，无需进一步纯化即具有较高的纯度，适合工业化生产。

USPTO Abstract

本发明属于药物合成技术领域，具体涉及一种2‑氨基‑6‑(1‑甲基哌啶‑4‑基羰基)吡啶的制备方法；本方法以2‑溴‑6‑(1‑甲基哌啶‑4‑基羰基)‑吡啶为起始原料，在L‑脯氨酸和催化剂作用下制得2‑氨基‑6‑(1‑甲基哌啶‑4‑基羰基)吡啶，可以有效降低杂质生成，且操作简单，反应条件温和，制得的化合物I收率高，无需进一步纯化即具有较高的纯度，适合工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN116925037B
Jurisdiction
CN
Classification
—
Expires
2026-04-07
Drug substance claim
No
Drug product claim
No
Assignee
Shandong New Time Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.